Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Flex Pharma (FLKS) Competitors

Flex Pharma logo

FLKS vs. OSTX, EGRX, AADI, NBRV, ELYM, HILS, NNVC, IBIO, AEON, and OBSV

Should you be buying Flex Pharma stock or one of its competitors? The main competitors of Flex Pharma include OS Therapies (OSTX), Eagle Pharmaceuticals (EGRX), Aadi Bioscience (AADI), Nabriva Therapeutics (NBRV), Eliem Therapeutics (ELYM), Hillstream BioPharma (HILS), NanoViricides (NNVC), iBio (IBIO), AEON Biopharma (AEON), and ObsEva (OBSV). These companies are all part of the "medical" sector.

Flex Pharma vs. Its Competitors

Flex Pharma (NASDAQ:FLKS) and OS Therapies (NYSE:OSTX) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, media sentiment, risk, valuation, dividends, profitability and analyst recommendations.

14.4% of Flex Pharma shares are owned by institutional investors. 7.6% of Flex Pharma shares are owned by insiders. Comparatively, 13.8% of OS Therapies shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

OS Therapies has a consensus price target of $18.00, indicating a potential upside of 940.46%. Given OS Therapies' stronger consensus rating and higher probable upside, analysts plainly believe OS Therapies is more favorable than Flex Pharma.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Flex Pharma
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
OS Therapies
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
2 Strong Buy rating(s)
3.40

OS Therapies has lower revenue, but higher earnings than Flex Pharma.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Flex Pharma$840K16.16-$21.92MN/AN/A
OS TherapiesN/AN/A-$7.79M-$0.86-2.01

In the previous week, OS Therapies had 3 more articles in the media than Flex Pharma. MarketBeat recorded 3 mentions for OS Therapies and 0 mentions for Flex Pharma. Flex Pharma's average media sentiment score of 0.00 equaled OS Therapies'average media sentiment score.

Company Overall Sentiment
Flex Pharma Neutral
OS Therapies Neutral

OS Therapies has a net margin of 0.00% compared to Flex Pharma's net margin of -1,208.42%. OS Therapies' return on equity of 0.00% beat Flex Pharma's return on equity.

Company Net Margins Return on Equity Return on Assets
Flex Pharma-1,208.42% -98.04% -83.37%
OS Therapies N/A N/A -569.57%

Summary

OS Therapies beats Flex Pharma on 9 of the 12 factors compared between the two stocks.

Get Flex Pharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for FLKS and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding FLKS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

FLKS vs. The Competition

MetricFlex PharmaPharmaceutical Preparations IndustryMedical SectorNASDAQ Exchange
Market Cap$13.58M$815.41M$5.73B$9.47B
Dividend YieldN/A4.84%4.60%3.99%
P/E RatioN/A1.3827.9319.95
Price / Sales16.1626.59438.49101.76
Price / CashN/A19.5636.5558.97
Price / Book1.476.818.655.90
Net Income-$21.92M-$4.28M$3.24B$258.42M

Flex Pharma Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
FLKS
Flex Pharma
N/A$0.75
+7.3%
N/A-67.3%$13.58M$840K0.004
OSTX
OS Therapies
2.2044 of 5 stars
$1.82
+7.7%
$18.00
+889.0%
N/A$51.14MN/A-2.12N/AGap Up
EGRX
Eagle Pharmaceuticals
2.5913 of 5 stars
$3.69
-0.3%
N/A-31.4%$47.92M$257.55M0.00100Gap Down
AADI
Aadi Bioscience
0.5171 of 5 stars
$1.85
+2.8%
$1.67
-9.9%
+28.0%$45.69M$25.07M-0.8140
NBRV
Nabriva Therapeutics
N/AN/AN/AN/A$45.46M$35.59M0.0070
ELYM
Eliem Therapeutics
N/A$1.51
+3.4%
N/A-82.9%$44.93MN/A-2.859
HILS
Hillstream BioPharma
N/A$1.69
+2.4%
N/A-47.0%$29.75MN/A-2.351Gap Up
NNVC
NanoViricides
0.4871 of 5 stars
$1.70
+0.6%
N/A-31.3%$27.32MN/A-2.3620
IBIO
iBio
1.3616 of 5 stars
$0.74
+1.2%
$5.00
+579.7%
-65.8%$12.00M$375K0.00100
AEON
AEON Biopharma
2.7313 of 5 stars
$0.80
-0.7%
$360.00
+44,676.1%
-99.6%$9.09MN/A4.475
OBSV
ObsEva
N/AN/AN/AN/A$7.94MN/A0.0050

Related Companies and Tools


This page (NASDAQ:FLKS) was last updated on 7/25/2025 by MarketBeat.com Staff
From Our Partners